Article info
PDFOriginal research
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia
- Correspondence to Mrs Yi-Shiu Lin, Department of Pharmacy, National Taiwan University Hospital, Taipei City 100229, Taiwan; yslin{at}ntuh.gov.tw
Citation
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia
Publication history
- Received October 16, 2020
- Revised December 29, 2020
- Accepted January 12, 2021
- First published February 19, 2021.
Online issue publication
October 18, 2023
Article Versions
- Previous version (14 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.